ArticleJournal of the American Chemical Society2026
Stenhouse Zwitterion Photoswitches as Hydrogen-Bond Acceptors.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Strategies for Enantioselective, Cascade, Valorizing, and Expanded Heterocyclic Piancatelli Rearrangements.ACS organic & inorganic Au · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Forming or disrupting hydrogen-bond pairs is a powerful strategy used to achieve selective chemical transformations and functions. Here, we introduce isolable sulfonamidate-iminium Stenhouse zwitterions, a class of photoswitches featuring hydrogen-bond-accepting capabilities. Unlike prior Stenhouse photoswitches necessitating C2 heteroatomic protonation for open-form stabilization, Stenhouse zwitterions remain in their open form with a C2 sulfonamidate anion when constructed with a sufficiently electron-withdrawing sulfonyl group. The sulfonamidate inverts the traditional C2 hydrogen-bond donor functionality into a hydrogen-bond acceptor, enabling hydrogen-bonding interactions that extend beyond acidochromism. Electronic changes in the sulfonyl group can also be leveraged to alter irradiative and nonirradiative isomeric distributions. Stenhouse zwitterion, hydrogen-bound zwitterion, and Stenhouse salt structural and behavioral patterns are differentiated by X-ray crystallography, NMR, and UV-vis control experiments. The chromophoric hydrogen-bond acceptor isomerizes to a colorless cyclic adduct with up to 96% efficiency upon visible light irradiation, with disruption of the hydrogen-bond interaction when in the hydrogen-bound form. A direct correlation between the triene electronic structure, nonirradiative equilibrium, photoswitching efficiency, and hydrogen-bonding capacity demonstrates the tunability of this platform.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.